Nexa Pharma Private Limited
About Nexa Pharma Private Limited
Data last updated:
Nexa Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 12 June 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21001TS2023PTC174138.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Govindareddy Katireddy and Deepali Yarrabapu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
Company details
Contact details
Nexa Pharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address# 1 – 5 – B/54, Afochs Colony 3rd Avenue, Hyderabad, Telangana, India – 500094
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nexa Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Nexa Pharma Private Limited, buy the company report.
Board of directors of Nexa Pharma Private Limited
Nexa Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Govindareddy Katireddy Also directs: Oscar Biopharma Private Limited, Planet India Remedies Private Limited, Ciro Labs Private Limited and 4 more | Director | 12 Jun 2023 | 3 Years 4 Months | Current |
| Deepali Yarrabapu Also directs: Oscar Biopharma Private Limited, Cygnus Micro Systems Pvt Ltd | Director | 12 Jun 2023 | 3 Years 4 Months | Current |
| Katireddy Nithin Reddy | Director | 12 Jun 2023 | 3 Years 4 Months | Current |
| Harshitha Reddy Katireddy Also directs: Oscar Biopharma Private Limited, Planet India Remedies Private Limited, Ciro Labs Private Limited and 1 more | Director | 12 Jun 2023 | 3 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Nexa Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nexa Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nexa Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nexa Pharma Private Limited has 4 board changes on record since 2023: 4 appointments. The latest: Deepali Yarrabapu was appointed as Director on 12 Jun 2023.
Frequently asked questions
Nexa Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in paper and paper products, within the paper industry. It was incorporated on 12 June 2023 (3+ years old) and is registered under CIN U21001TS2023PTC174138.
Nexa Pharma has 4 current directors:
- Govindareddy Katireddy - Director
- Deepali Yarrabapu - Director
- Katireddy Nithin Reddy - Director
- Harshitha Reddy Katireddy - Director
The latest financial statements of Nexa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Nexa Pharma is U21001TS2023PTC174138. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nexa Pharma was incorporated on 12 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
Deepali Yarrabapu was appointed as Director on 12 Jun 2023. Govindareddy Katireddy was appointed as Director on 12 Jun 2023. Harshitha Reddy Katireddy was appointed as Director on 12 Jun 2023. Nexa Pharma has 4 board changes on record in total.
The registered office of Nexa Pharma is at # 1 – 5 – B54, Afochs Colony 3rd Avenue, Hyderabad, Telangana, India – 500094.
Nexa Pharma operates in the paper industry, in the paper and paper products segment.
Nexa Pharma can be reached at its registered office: # 1 – 5 – B54, Afochs Colony 3rd Avenue, Hyderabad, Telangana, India – 500094.
Nexa Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
